BG61120B2 - Производни на 1,2,5,6-тетрахидропиридин-3-карбоксалдехид оксим,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави - Google Patents

Производни на 1,2,5,6-тетрахидропиридин-3-карбоксалдехид оксим,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави Download PDF

Info

Publication number
BG61120B2
BG61120B2 BG098527A BG9852794A BG61120B2 BG 61120 B2 BG61120 B2 BG 61120B2 BG 098527 A BG098527 A BG 098527A BG 9852794 A BG9852794 A BG 9852794A BG 61120 B2 BG61120 B2 BG 61120B2
Authority
BG
Bulgaria
Prior art keywords
formula
compound
radical
compounds
tetrahydropyridine
Prior art date
Application number
BG098527A
Other languages
Bulgarian (bg)
English (en)
Inventor
Giulio Galliani
Fernando Barzaghi
Alina Butti
Carla Bonetti
Emilio Toja
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT19565/86A external-priority patent/IT1191667B/it
Priority claimed from IT21157/86A external-priority patent/IT1196510B/it
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG61120B2 publication Critical patent/BG61120B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
BG098527A 1986-02-27 1994-02-23 Производни на 1,2,5,6-тетрахидропиридин-3-карбоксалдехид оксим,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави BG61120B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19565/86A IT1191667B (it) 1986-02-27 1986-02-27 Derivati della 1,2,5,6-tetraidropiridin-3-carbossaldeide ossima,loro procedimento di preparazione e loro applicazione come farmaci
IT21157/86A IT1196510B (it) 1986-07-17 1986-07-17 Derivati della 1,2-5,6-tetraidropiridin-3-carbossaldeide ossima,loro procedimento di preparazione e loro applicazione come farmaci

Publications (1)

Publication Number Publication Date
BG61120B2 true BG61120B2 (bg) 1996-11-29

Family

ID=26327212

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098527A BG61120B2 (bg) 1986-02-27 1994-02-23 Производни на 1,2,5,6-тетрахидропиридин-3-карбоксалдехид оксим,метод за получаването им,приложението им като лекарствени средства и съдържащите ги състави

Country Status (20)

Country Link
US (3) US5219872A (de)
EP (1) EP0239445B1 (de)
JP (1) JPH07599B2 (de)
KR (1) KR950005197B1 (de)
AT (1) ATE76066T1 (de)
AU (1) AU588972B2 (de)
BG (1) BG61120B2 (de)
CA (1) CA1327803C (de)
DE (1) DE3778951D1 (de)
DK (1) DK167803B1 (de)
ES (1) ES2032456T3 (de)
FI (1) FI87199C (de)
GR (1) GR3004845T3 (de)
HK (1) HK29797A (de)
HU (1) HU198018B (de)
IE (1) IE59095B1 (de)
IL (1) IL81610A (de)
NO (1) NO172180C (de)
NZ (1) NZ219416A (de)
PT (1) PT84366B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
IT1222526B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
IT1233446B (it) * 1987-12-30 1992-04-01 Roussel Maestretti Spa Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
US5110828A (en) * 1988-04-15 1992-05-05 Beecham Group P.L.C. Azabicyclo oxime derivatives
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
US5278170A (en) * 1989-04-13 1994-01-11 Beecham Group P.L.C. Azabicylo oxime compounds
IT1240603B (it) * 1990-03-14 1993-12-17 Roussel Maestretti Spa Derivati della 1,2,5,6-tetraidropiridina 3- carbossaldeide ossima, loro procedimento di preparazione e loro impiego come sostanza medicinale
IT1241138B (it) * 1990-05-15 1993-12-29 Roussel Pharma Derivati dell'ossina della 1,2,5,6- tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
EP0544773B1 (de) * 1990-08-24 1998-03-18 Beecham Group Plc Azabicyclische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
EP0552213A1 (de) * 1990-10-12 1993-07-28 Beecham Group Plc 1,2,5,6-tetrahydropyridinoximderivate
AU3142793A (en) * 1991-12-18 1993-07-19 Warner-Lambert Company Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
WO1994007493A1 (en) * 1992-10-06 1994-04-14 Warner-Lambert Company Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
US5731314A (en) * 1995-01-06 1998-03-24 Bencherif; Merouane Pharamceutical compositions for prevention and treatment of tourette's syndrome
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US6455648B1 (en) 1999-12-29 2002-09-24 Chevron Phillips Chemical Company Lp Olefin production
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US9877500B2 (en) * 2007-03-14 2018-01-30 Concentrate Manufacturing Company Of Ireland Natural beverage products
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CH704993A1 (fr) 2011-05-20 2012-11-30 Bacab S A Câble électrique.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004979A (en) * 1961-10-17 Oximes of certain tetrahydropyridine
FR1258847A (fr) * 1960-02-12 1961-04-21 Ciba Geigy Procédé de préparation de nouveaux dérivés pyridiniques, entre autres de l'oxime de la l-méthyl-3 ou 4-acétyl-1, 2, 5, 6-tétrahydropyridine
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti

Also Published As

Publication number Publication date
FI870842A0 (fi) 1987-02-26
AU588972B2 (en) 1989-09-28
US5532375A (en) 1996-07-02
IE59095B1 (en) 1994-01-12
ES2032456T3 (es) 1993-02-16
US5219872A (en) 1993-06-15
CA1327803C (en) 1994-03-15
EP0239445A3 (en) 1989-01-18
IL81610A0 (en) 1987-09-16
FI87199C (fi) 1992-12-10
US5391754A (en) 1995-02-21
NO172180C (no) 1993-06-16
ATE76066T1 (de) 1992-05-15
IL81610A (en) 1990-12-23
JPH07599B2 (ja) 1995-01-11
KR950005197B1 (ko) 1995-05-19
AU6927987A (en) 1987-09-03
HU198018B (en) 1989-07-28
GR3004845T3 (de) 1993-04-28
NZ219416A (en) 1989-04-26
DK98787D0 (da) 1987-02-26
PT84366B (pt) 1989-10-04
PT84366A (en) 1987-03-01
DK167803B1 (da) 1993-12-20
JPS62252767A (ja) 1987-11-04
DE3778951D1 (de) 1992-06-17
EP0239445B1 (de) 1992-05-13
DK98787A (da) 1987-08-28
IE870497L (en) 1987-08-27
NO870771D0 (no) 1987-02-25
HUT44497A (en) 1988-03-28
FI870842L (fi) 1987-08-28
FI87199B (fi) 1992-08-31
HK29797A (en) 1997-03-21
NO172180B (no) 1993-03-08
KR870007890A (ko) 1987-09-22
EP0239445A2 (de) 1987-09-30
NO870771L (no) 1987-08-28

Similar Documents

Publication Publication Date Title
KR950005197B1 (ko) 1,2,5,6-테트라히드로피리딘-3-카르복시 알데히드 옥심유도체의 제조방법
EP1428534B1 (de) Benzofurazanderivate und deren verwendung zur verbesserung glutaminerger synaptischer antworten
JPS6340792B2 (de)
JPS631312B2 (de)
JP2727192B2 (ja) 新規の１，２，５，６−テトラヒドロピリジン誘導体、それらの製造方法、それらの薬剤としての使用及びそれらを含有する組成物
EP3700895B1 (de) Polycyclische amide als muscarin-m1-rezeptor-positive allosterische modulatoren
US5015655A (en) 1-azabicycloalkane derivatives, their preparation process and their use as medicaments
JP2660430B2 (ja) 新規の１，２，５，６−テトラヒドロピリジン−３−カルボキサアルデヒドのオキシム誘導体、それらの製造方法、それらの薬剤としての使用及びそれらを含有する組成物
CA1095047A (fr) Procede de preparation de nouveaux derives du 1,4- benzodioxane
US4927837A (en) Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments
US4921868A (en) Carbamate derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, their use as medicaments and compositions containing them
US5219873A (en) Compounds of 1,2,5,6-tetrahydropyridine which are useful as cholinergic agents
EP1622892B1 (de) Indazole mit analgetischer aktivität
PT93228A (pt) Processos para a preparacao de novos derivados da 1-arilsulfonil 2-piperidona e de composicoes farmaceuticas que os contem
NL8703003A (nl) Nieuwe azaspirodecaanverbindingen, hun zouten, werkwijze voor hun bereiding, hun toepassing als geneesmiddelen en preparaten, die hen bevatten.
JPH11506470A (ja) 新規複素環式化合物
US5183893A (en) 1-azabicycloalkane derivatives, their preparation process and their use as medicaments
US5183896A (en) Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime
JPS631305B2 (de)
SU1498387A3 (ru) Способ получени производных 1,2,5,6 - тетрагидропиридин-3-карбоксальдегидоксима или их гидрохлоридов
WO2005030720A1 (ja) Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体
FR2470128A2 (fr) Nouveaux derives du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
HK1087705B (en) Indazoles having analgesic activity